BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Akakura K, Uemura H, Kawakami S, et al. (2024) Metastatic castration resistant prostate cancer patients' experience with Radium-223 treatment in Japan. Future Oncology (London, England). 20: 781-798 |
Yamamoto Y, Ishii M, Yoshimura A, et al. (2022) Efficacy of cabazitaxel in patients with metastatic castration-resistant prostate cancer: A single-center study in Japan. International Journal of Urology : Official Journal of the Japanese Urological Association |
Sugimoto K, Tabuchi T, Okawa S, et al. (2021) Hospital volume and postoperative survival for three urological cancers: Prostate, kidney, and bladder. International Journal of Urology : Official Journal of the Japanese Urological Association |
Iguchi T, Kimura G, Fukasawa S, et al. (2021) Enzalutamide with androgen deprivation therapy in Japanese men with metastatic hormone-sensitive prostate cancer: A subgroup analysis of the phase III ARCHES study. International Journal of Urology : Official Journal of the Japanese Urological Association |
Uemura H, Arai G, Uemura H, et al. (2020) Apalutamide for metastatic, castration-sensitive prostate cancer in the Japanese population: A subgroup analysis of the randomized, double-blind, placebo-controlled phase 3 TITAN study. International Journal of Urology : Official Journal of the Japanese Urological Association |
Nakai Y, Kanaki T, Yamamoto A, et al. (2020) Antiresorptive agent-related osteonecrosis of the jaw in prostate cancer patients with bone metastasis treated with bone-modifying agents. Journal of Bone and Mineral Metabolism |
Yamamoto Y, Okuda Y, Kanaki T, et al. (2020) Clinical indicators for predicting prognosis after radium-223 administration in castration-resistant prostate cancer with bone metastases. International Journal of Clinical Oncology |
Tomita Y, Tatsugami K, Nakaigawa N, et al. (2020) Cabozantinib in advanced renal cell carcinoma: A phase II, open-label, single-arm study of Japanese patients. International Journal of Urology : Official Journal of the Japanese Urological Association |
Asakura T, Nakai Y, Oka T, et al. (2020) [A Case of Myocardial Metastasis of Renal Cell Cancer Treated with Nivolumab]. Hinyokika Kiyo. Acta Urologica Japonica. 66: 225-228 |
Ito K, Kobayashi M, Komiyama M, et al. (2020) Oncological outcomes for patients with locally advanced prostate cancer treated with neoadjuvant endocrine and external-beam radiation therapy followed by adjuvant continuous/intermittent endocrine therapy in an open-label, randomized, phase 3 trial. Cancer |